Silence Therapeutics (SLN) Stock Rating Reaffirmed by Peel Hunt
Silence Therapeutics stock opened at GBX 49.40 ($0.65) on Monday. The company has a market capitalization of $35.11 million and a price-to-earnings ratio of -7.26. Silence Therapeutics has a 1 year low of GBX 46.10 ($0.60) and a 1 year high of GBX 202 ($2.64).
About Silence Therapeutics
Read More: Trading Ex-Dividend
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.